Publications by authors named "Janey Stone"

Claim this Profile
A
A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma.
Greg Hapgood, Janey M Stone, Diana Zannino, Anup George, Paula Marlton

Leuk Lymphoma· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03).
Andrew Wirth, H Miles Prince, Daniel Roos, John Gibson, Peter O'Brien, Janey M Stone

Int J Radiat Oncol Biol Phys· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
Mark Hertzberg, Jane Palfrey Matthews, Janey Malka Stone, Ming-Celine Dubosq, Andrew Grigg

Am J Hematol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group.
Andrew Wirth, Andrew Grigg, Max Wolf, David Goldstein, Carol Johnson, Janey Stone

Leuk Lymphoma· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma.
Andrew P Grigg, Janey Stone, Alvin D Milner, Anthony P Schwarer, Max Wolf

Leuk Lymphoma· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Janine Campbell, John F Seymour, Jane Matthews, Max Wolf, Janey Stone

Eur J Haematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis